Dying of Cancer, Ben Sasse Says 'Miracle Drug' Shrank Tumors and Caused Bloody Face - TODAY.com
Dying of Cancer, Ben Sasse Says 'Miracle Drug' Shrank Tumors and Caused Bloody Face TODAY.com
Pancreatic Cancer News
Former Sen. Ben Sasse, living with terminal cancer, sees an opportunity in living on a deadline - CBS News
Former Sen. Ben Sasse, living with terminal cancer, sees an opportunity in living on a deadline CBS News
Ben Sasse Says He's 'Living on Extended Time' amid Stage 4 Pancreatic Cancer - People.com
Ben Sasse Says He's 'Living on Extended Time' amid Stage 4 Pancreatic Cancer People.com
Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy - statnews.com
Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy statnews.com
Erasca hits ‘home run’ with cancer data as analyst suggests stock drop prompted by patient death - Fierce Biotech
Erasca hits ‘home run’ with cancer data as analyst suggests stock drop prompted by patient death Fierce Biotech
Erasca think it can best RevMed in RAS war, but patient death gives investors pause - FirstWord Pharma
Erasca think it can best RevMed in RAS war, but patient death gives investors pause FirstWord Pharma
The Turning Point in Pancreatic Cancer is Here - Pancreatic Cancer Action Network
The Turning Point in Pancreatic Cancer is Here Pancreatic Cancer Action Network
Man Visited the Doctor 24 Times in One Year for Pain Before Receiving a Cancer Diagnosis. He Died 12 Days Later - People.com
Man Visited the Doctor 24 Times in One Year for Pain Before Receiving a Cancer Diagnosis. He Died 12 Days Later People.com
Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processing - Nature
Cancer-associated fibroblasts regulate DNA repair in pancreatic cancer through NDRG1-mediated R-loop processing Nature
New Roswell Park study finds pill may nearly double survival for pancreatic cancer - WGRZ
New Roswell Park study finds pill may nearly double survival for pancreatic cancer WGRZ
There’s a Revolution in Cancer. But Can Big Pharma Afford It? - WSJ
There’s a Revolution in Cancer. But Can Big Pharma Afford It? WSJ
Researchers from The Wistar Institute and ChristianaCare identify promising new therapeutic target for pancreatic cancer - EurekAlert!
Researchers from The Wistar Institute and ChristianaCare identify promising new therapeutic target for pancreatic cancer EurekAlert!
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up - BioSpace
Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up BioSpace
Car cruise benefits Saxonburg man diagnosed with Stage 4 cancer - Butler Eagle
Car cruise benefits Saxonburg man diagnosed with Stage 4 cancer Butler Eagle
Former Sen. Ben Sasse, dying of cancer, reflects on family, faith and the future of America - CBS News
Former Sen. Ben Sasse, dying of cancer, reflects on family, faith and the future of America CBS News
A Community Unites to End Pancreatic Cancer at PurpleStride 2026 - Pancreatic Cancer Action Network
A Community Unites to End Pancreatic Cancer at PurpleStride 2026 Pancreatic Cancer Action Network
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer - Nature
Dual targeting of PI3Kγ and STING overcomes regulatory B cell- and myeloid cell-driven immune suppression in pancreatic cancer Nature
Opinion: This potential pancreatic cancer treatment breakthrough should be celebrated - Yakima Herald-Republic
Opinion: This potential pancreatic cancer treatment breakthrough should be celebrated Yakima Herald-Republic
Affordable biosensor to early detect pancreatic cancer - healthcare-in-europe.com
Affordable biosensor to early detect pancreatic cancer healthcare-in-europe.com
Biotech Hammered Despite 'Phenomenal' Data; Here's Why - Investor's Business Daily
Biotech Hammered Despite 'Phenomenal' Data; Here's Why Investor's Business Daily
Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug - Yahoo
Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug Yahoo
A Look At Revolution Medicines (RVMD) Valuation After Breakthrough Pancreatic Cancer Trial Results - simplywall.st
A Look At Revolution Medicines (RVMD) Valuation After Breakthrough Pancreatic Cancer Trial Results simplywall.st
Why these treatments for one of the deadliest cancers are stirring such hope - The Washington Post
Why these treatments for one of the deadliest cancers are stirring such hope The Washington Post
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer - Nature
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer Nature
Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer - Nature
Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer Nature
Pancreatic Cancer Action Network Rallies Thousands Nationwide at PanCAN PurpleStride – Inspiring Hope and Raising Critical Funds for the Fight Against Pancreatic Cancer - Pancreatic Cancer Action Network
Pancreatic Cancer Action Network Rallies Thousands Nationwide at PanCAN PurpleStride – Inspiring Hope and Raising Critical Funds for the Fight Against Pancreatic Cancer Pancreatic Cancer Action Network
PurpleStride Pittsburgh raises nearly $500,000 to fight pancreatic cancer - CBS News
PurpleStride Pittsburgh raises nearly $500,000 to fight pancreatic cancer CBS News
This could be the biggest breakthrough in pancreatic cancer in decades - National Geographic
This could be the biggest breakthrough in pancreatic cancer in decades National Geographic
Silexion Therapeutics Submits Clinical Trial Application for SIL204 in Phase 2/3 Trial for Locally Advanced Pancreatic Cancer in Germany - Quiver Quantitative
Silexion Therapeutics Submits Clinical Trial Application for SIL204 in Phase 2/3 Trial for Locally Advanced Pancreatic Cancer in Germany Quiver Quantitative
Ron DePinho: A Notable Translational Signal in Pancreatic Cancer - Oncodaily
Ron DePinho: A Notable Translational Signal in Pancreatic Cancer Oncodaily
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing Memorial Sloan Kettering Cancer Center
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer - The New York Times
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer The New York Times
Pancreatic cancer pill shown to nearly double overall survival time, drug company says - The Hill
Pancreatic cancer pill shown to nearly double overall survival time, drug company says The Hill
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease - WSJ
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease WSJ
Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug - FOX 8 TV
Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug FOX 8 TV
Pancreatic Cancer Vaccine Still Shows Promise 6 Years Out - Medscape
Pancreatic Cancer Vaccine Still Shows Promise 6 Years Out Medscape
From Benign Growth to Pancreatic Cancer: New Study Shows How the Switch Gets Flipped - Memorial Sloan Kettering Cancer Center
From Benign Growth to Pancreatic Cancer: New Study Shows How the Switch Gets Flipped Memorial Sloan Kettering Cancer Center
Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers - UCLA Health
Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers UCLA Health
Pancreatic cancer drug SIL204 moves toward EU mid-stage trial - Stock Titan
Pancreatic cancer drug SIL204 moves toward EU mid-stage trial Stock Titan
Announcing PanCAN’s $250 Million All Together We Can Campaign - Pancreatic Cancer Action Network
Announcing PanCAN’s $250 Million All Together We Can Campaign Pancreatic Cancer Action Network